Variation in incidence and survival by ethnicity for patients with myeloma in England (2002–2008)

References

• Cancer Research UK. Cancer incidence for common cancers [Internet]. Available from: www.cancerresearchuk.org/cancer-info/cancerstats/incidence/commoncancers/
   Google Scholar
• Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon: IARC. Available from: http://globocan.iarc.fr
   Google Scholar
• Landgren O, Kyle RA, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 2009;113:5412–5417.
   PubMed Web of Science ®Google Scholar
• Kyle RA, Durie BG, Rajkumar SV, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 2010;24:1121–1127.
   PubMed Web of Science ®Google Scholar
• Waxman AJ, Mink PJ, Devesa SS, et al. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood 2010;116:5501–5506.
   PubMed Web of Science ®Google Scholar
• Carreon JD, Morton LM, Devesa SS, et al. Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996–2004. Cancer Causes Control 2008;19:1171–1181.
   PubMed Web of Science ®Google Scholar
• Axtell LM, Myers MH. Contrasts in survival of black and white cancer patients, 1960-73. J Natl Cancer Inst 1978;60:1209–1215.
   PubMed Web of Science ®Google Scholar
• Han X, Kilfoy B, Zheng T, et al. Lymphoma survival patterns by WHO subtype in the United States, 1973–2003. Cancer Causes Control 2008;19:841–858.
   PubMed Web of Science ®Google Scholar
• Ailawadhi S, Aldoss IT, Yang D, et al. Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups. Br J Haematol 2012;158:91–98.
   PubMed Web of Science ®Google Scholar
• Pulte D, Redaniel MT, Brenner H, et al. Changes in survival by ethnicity of patients with cancer between 1992–1996 and 2002–2006: is the discrepancy decreasing? Ann Oncol 2012;23:2428–2434.
   PubMed Web of Science ®Google Scholar
• National Cancer Intelligence Network Coordinating Centre. Cancer incidence and survival by major ethnic group, England, 2002–2006 [Internet]. National Cancer Intelligence Network 2009. Available from: www.ncin.org.uk/view.aspx?rid = 75
   Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373–383.
   PubMedGoogle Scholar
• Office of the Deputy Prime Minister. The English Indices of Deprivation 2004: Summary (revised). London; 2005.
   Google Scholar
• Downing A, West RM, Gilthorpe MS, et al. Using routinely collected health data to investigate the association between ethnicity and breast cancer incidence and survival: what is the impact of missing data and multiple ethnicities? Ethnic Health 2011; 16:201–212.
   PubMed Web of Science ®Google Scholar
• Royston P. Multiple imputation of missing values: update of ICE. Stata J 2005;5:527–536.
   Web of Science ®Google Scholar
• Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. Br Med J 2009;338:b2393.
   PubMed Web of Science ®Google Scholar
• Nanchahal K, Mangtani P, Alston M, et al. Development and validation of a computerized South Asian Names and Group Recognition Algorithm (SANGRA) for use in British health-related studies. J Public Health Med 2001;23:278–285.
   PubMedGoogle Scholar
• Cummins C, Winter H, Cheng KK, et al. An assessment of the Nam Pehchan computer program for the identification of names of south Asian ethnic origin. J Public Health Med 1999;21:401–406.
   PubMedGoogle Scholar
• Boyle P, Parkin DM, Jenson OM, et al. Statistical methods for registries. In: Cancer registration: principles and methods. Lyon: IARC; 1991. pp 126–158.
   Google Scholar
• Brenner H, Arndt V, Gefeller O, et al. An alternative approach to age adjustment of cancer survival rates. Eur J Cancer 2004;40: 2317–2322.
   PubMed Web of Science ®Google Scholar
• Cronin KA, Feuer EJ. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. Stat Med 2000;19:1729–1740.
   PubMed Web of Science ®Google Scholar
• Dickman PW, Sloggett A, Hills M, et al. Regression models for relative survival. Stat Med 2004;23:51–64.
   PubMed Web of Science ®Google Scholar
• Perme MP, Stare J, Esteve J. On estimation in relative survival. Biometrics 2012;68:113–120.
   PubMed Web of Science ®Google Scholar
• Ries LAG, Eisner MP, Kosary CL, et al., editors. SEER Cancer Statistics Review, 1973–1999. Bethesda, MD: National Cancer Institute; 2002.
   Google Scholar
• Shirley MH, Sayeed S, Barnes I, et al. Incidence of haematological malignancies by ethnic group in England, 2001-7. Br J Haematol 2013; 163:465–477.
   PubMed Web of Science ®Google Scholar
• Landgren O, Katzmann JA, Hsing AW, et al. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc 2007;82:1468–1473.
   PubMed Web of Science ®Google Scholar
• Landgren O, Gridley G, Turesson I, et al. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood 2006;107:904–906.
   PubMed Web of Science ®Google Scholar
• Cohen HJ, Crawford J, Rao MK, et al. Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly. Am J Med 1998;104:439–444.
   PubMed Web of Science ®Google Scholar
• Winter H, Cheng KK, Cummins C, et al. Cancer incidence in the south Asian population of England (1990-92). Br J Cancer 1999;79: 645–654.
   PubMed Web of Science ®Google Scholar
• Ali R, Barnes I, Kan SW, et al. Cancer incidence in British Indians and British whites in Leicester, 2001–2006. Br J Cancer 2010; 103:143–148.
   PubMed Web of Science ®Google Scholar
• Smith A, Roman E, Howell D, et al. The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research. Br J Haematol 2010;148:739–753.
   PubMed Web of Science ®Google Scholar
• Haematological Malignancy Research Network. Haematological malignancies & cancer registration in England (2004–2008). Quality appraisal comparing data from the National Cancer Data Repository (NCDR) with the population-based Haematological Malignancy Research Network (HMRN). Final Report. London: HMRN; 2012.
   Google Scholar
• Blakely T, Soeberg M, Carter K, et al. Bias in relative survival methods when using incorrect life-tables: lung and bladder cancer by smoking status and ethnicity in New Zealand. Int J Cancer 2012; 131:E974–E982.
   PubMed Web of Science ®Google Scholar
• Morris M, Rachet B, Woods LM. A novel methodology for constructing ethnic majority life tables: an analysis of routine data from England and Wales. Lancet 2013;382:S76.
   Web of Science ®Google Scholar
• Weiss BM. Multiethnic myeloma. Blood 2013;121:3062–3064.
   PubMed Web of Science ®Google Scholar
• Landgren O, Weiss BM. Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis. Leukemia 2010;23:1691–1697.
   Web of Science ®Google Scholar
• Weiss BM, Minter A, Abadie J, et al. Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients. Am J Hematol 2011; 86:475–478.
   PubMed Web of Science ®Google Scholar
• Baker A, Braggio E, Jacobus S, et al. Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach. Blood 2013;121:3147–3152.
   PubMed Web of Science ®Google Scholar
• Albain KS, Unger JM, Crowley JJ, et al. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst 2009;101:984–992.
   PubMed Web of Science ®Google Scholar
• Modiano MR, Villar-Werstler P, Crowley J, et al. Evaluation of race as a prognostic factor in multiple myeloma. An ancillary of Southwest Oncology Group Study 8229. J Clin Oncol 1996;14:974–977.
   PubMed Web of Science ®Google Scholar
• Rajkumar SV, Jacobus S, Callander NS, et al. Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial. Lancet Oncol 2010;11:29–37.
   PubMed Web of Science ®Google Scholar
• Hari PN, Majhail NS, Zhang MJ, et al. Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 2010;16:395–402.
   PubMed Web of Science ®Google Scholar
• Verma PS, Howard RS, Weiss BM. The impact of race on outcomes of autologous transplantation in patients with multiple myeloma. Am J Hematol 2008;83:355–358.
   PubMed Web of Science ®Google Scholar
• Auner HW, Pavlu J, Szydlo R, et al. Autologous haematopoietic stem cell transplantation in multiple myeloma patients from ethnic minority groups in an equal access healthcare system. Br J Haematol 2012;157:125–127.
   PubMed Web of Science ®Google Scholar
• Joshua TV, Rizzo JD, Zhang MJ, et al. Access to hematopoietic stem cell transplantation: effect of race and sex. Cancer 2010;116: 3469–3476.
   PubMed Web of Science ®Google Scholar
• Warren JL, Harlan LC, Stevens J, et al. Multiple myeloma treatment transformed: a population-based study of changes in initial management approaches in the United States. J Clin Oncol 2013;31:1984–1989.
   PubMed Web of Science ®Google Scholar